Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TRUSTID, Inc. v. Next Caller Inc.
Case Number:
1:18-cv-00172
Court:
Nature of Suit:
Judge:
Firms
-
January 06, 2022
Judge Axes Tech Co.'s $3M Win In False Ad Fight
A Delaware federal judge has undone a jury's finding that venture capital-backed Next Caller owed nearly $3 million for falsely advertising caller-authentication security capabilities.
-
July 19, 2021
Jury Hands Tech Co. $3M, But Rejects Infringement Claims
A federal jury in Delaware has turned down patent infringement claims leveled by a Neustar Inc. unit, but ordered venture capital-backed Next Caller to pay nearly $3 million for falsely advertising caller-authentication security capabilities.
-
July 12, 2021
Tech Co. Blasted For Violating Protective Order In IP Dispute
A Delaware federal judge on Monday slammed caller-authentication company TrustID Inc. for repeatedly violating a protective order by its handling of rival Next Caller Inc.'s source code, saying that TrustID's actions "threaten the credibility of the court" to maintain confidentiality.
-
July 08, 2021
IP Forecast: Daiichi Sankyo Unit Takes Drug Rival To A Jury
Attorneys who are vaccinated will be allowed to go maskless before a jury on Monday in a Daiichi Sankyo unit's patent suit in California federal court alleging Novartis is infringing its billion-dollar skin cancer treatment. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.